Ignite Creation Date:
2024-05-06 @ 12:04 AM
Last Modification Date:
2024-10-26 @ 10:44 AM
Study NCT ID:
NCT01482767
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
2011-11-28
Brief Title:
Evaluating the Effectiveness of Boceprevir Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus HCV Infection in Adults With HIV and HCV Infection
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
262
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: